ebroadsheet13h
‘A Serious Risk, Particularly to the Most Vulnerable’
Ending funding for ongoing studies will amount to a denial of the kind of care that sick responders and survivors need and ...
Frontiers15h
Exploring Autoantibody Roles in Co-occurring SLE and Sjögren’s Disease
Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...
Frontiers18h
Synergies and Surprises - Unravelling the Mutual Influence of Sjögren's and Systemic Lupus Erythematosus
Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...
Healio19h
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...